CLINICAL_TRIALS ClinicalTrials.gov record update

A Two-Arm, Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00628238
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:02.634178+00:00
Published At: 2010-09-10T00:00:00+00:00
Record Updated At: 2010-09-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Chronic Lymphocytic Leukemia", "CLL", "Untreated", "Front-line", "First-Line", "Initial Therapy"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2010-09-10"
protocolSection.identificationModule.nctId: "NCT00628238"
protocolSection.identificationModule.officialTitle: "A Two-Arm, Multi-center Trial of Revlimid\u00ae and Rituximab, for First-Line Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.